PubMed

Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance.

Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM.

Arch Intern Med. 2009 Nov 23;169(21):1976-85.PMID: 19933959 [PubMed - in process]Related articles

The ADVANTAGE seeding trial: a review of internal documents.

Hill KP, Ross JS, Egilman DS, Krumholz HM.

Ann Intern Med. 2008 Aug 19;149(4):251-8. Review.PMID: 18711155 [PubMed - indexed for MEDLINE]Related articlesFree article

IJOEH and the critique of bias.

Egilman DS, Bohme SR.

Int J Occup Environ Health. 2008 Apr-Jun;14(2):147-51. No abstract available. PMID: 18507293 [PubMed - indexed for MEDLINE]Related articles

Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.

Ross JS, Hill KP, Egilman DS, Krumholz HM.

JAMA. 2008 Apr 16;299(15):1800-12.PMID: 18413874 [PubMed - indexed for MEDLINE]Related articlesFree article

American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry.

LaDou J, Teitelbaum DT, Egilman DS, Frank AL, Kramer SN, Huff J.

Int J Occup Environ Health. 2007 Oct-Dec;13(4):404-26. Review.PMID: 18085054 [PubMed - indexed for MEDLINE]Related articles

Avoiding the regulatory capture of the Food and Drug Administration.

Egilman DS, Presler AH, Valentin CS.

Arch Intern Med. 2007 Apr 9;167(7):732-3. No abstract available. PMID: 17420438 [PubMed - indexed for MEDLINE]Related articles

What have we learnt from Vioxx?

Krumholz HM, Ross JS, Presler AH, Egilman DS.

BMJ. 2007 Jan 20;334(7585):120-3. Review. No abstract available. PMID: 17235089 [PubMed - indexed for MEDLINE]Related articles

Differential peeky bias.

Egilman DS, Billings MA.

Int J Occup Environ Health. 2006 Jul-Sep;12(3):294. No abstract available. PMID: 16967841 [PubMed - indexed for MEDLINE]Related articles

Report of specific cardiovascular outcomes of the ADVANTAGE trial.

Egilman DS, Presler AH.

Ann Intern Med. 2006 May 16;144(10):781. No abstract available. Erratum in: Ann Intern Med. 2006 Jun 20;144(12):943. PMID: 16702599 [PubMed - indexed for MEDLINE]Related articlesFree article

Chevron-Texaco's science.

Egilman DS, Bohme SR.

Int J Occup Environ Health. 2005 Oct-Dec;11(4):456-7. No abstract available. PMID: 16350480 [PubMed - indexed for MEDLINE]Related articles

Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability.

Egilman DS, Billings MA.

Int J Occup Environ Health. 2005 Oct-Dec;11(4):360-71.PMID: 16350470 [PubMed - indexed for MEDLINE]Related articles

Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation.

Bohme SR, Zorabedian J, Egilman DS.

Int J Occup Environ Health. 2005 Oct-Dec;11(4):338-48.PMID: 16350467 [PubMed - indexed for MEDLINE]Related articles

Over a barrel: corporate corruption of science and its effects on workers and the environment.

Egilman DS, Bohme SR.

Int J Occup Environ Health. 2005 Oct-Dec;11(4):331-7.PMID: 16350466 [PubMed - indexed for MEDLINE]Related articles

Suppression bias at the Journal of Occupational and Environmental Medicine.

Egilman DS.

Int J Occup Environ Health. 2005 Apr-Jun;11(2):202-4.PMID: 15875897 [PubMed - indexed for MEDLINE]Related articles

The beryllium "double standard" standard.

Egilman DS, Bagley S, Biklen M, Golub AS, Bohme SR.

Int J Health Serv. 2003;33(4):769-812.PMID: 14758859 [PubMed - indexed for MEDLINE]Related articles

Handling conflicts of interest between industry and academia.

Egilman DS, Ehrle LH.

JAMA. 2003 Jun 25;289(24):3240; author reply 3240-1. No abstract available. PMID: 12824203 [PubMed - indexed for MEDLINE]Related articles

Corruption of previously published asbestos research.

Egilman DS, Reinert A.

Arch Environ Health. 2000 Jan-Feb;55(1):75-6. No abstract available. PMID: 10735525 [PubMed - indexed for MEDLINE]Related articles

Breast implant verdicts resulted from corporate misconduct and legitimate science.

Egilman DS, Walta M.

Am J Public Health. 1999 Nov;89(11):1763-4. No abstract available. PMID: 10553407 [PubMed - indexed for MEDLINE]Related articlesFree article

Corruption of the medical literature: a second visit.

Egilman DS, Hom CM.

Am J Ind Med. 1998 Oct;34(4):401-4; discussion 409-10. No abstract available. PMID: 9750948 [PubMed - indexed for MEDLINE]Related articles

Evaluating the health risks of breast implants.

Egilman DS, Stubbs C.

N Engl J Med. 1996 Oct 10;335(15):1154-5; author reply 1156. No abstract available. PMID: 8848018 [PubMed - indexed for MEDLINE]Related articles

Mesothelioma: An unwarranted causal model.

Egilman DS, Goldin AS, Goldin GA.

J Occup Environ Med. 1996 Mar;38(3):239-40. No abstract available. PMID: 8882093 [PubMed - indexed for MEDLINE]Related articles

The origin and development of the asbestos Threshold Limit Value: scientific indifference and corporate influence.

Egilman DS, Reinert AA.

Int J Health Serv. 1995;25(4):667-96. Review.PMID: 8575867 [PubMed - indexed for MEDLINE]Related articles

Public health and epistemology.

Egilman DS.

Am J Ind Med. 1992;22(3):457-9. No abstract available. PMID: 1519630 [PubMed - indexed for MEDLINE]Related articles